Skip to main content
. 2017 Sep 23;8(49):86592–86603. doi: 10.18632/oncotarget.21246

Figure 1. miR-29a-3p expression level in 62 patient samples.

Figure 1

(A) QRT-PCR analysis of miR-29a-3p expression in 62 HCC tissue samples and their corresponding adjacent non-tumorous liver samples (***P < 0.001). The expression of miR-29a-3p was normalized to U6 snRNA. (B) Kaplan-Meier analysis associated with overall survival for low and high miR-29a-3p expression (P < 0.001).